Sensitive periods for developmental toxicity of orally administered artesunate in the rat
Authors:
- Tacey E.K. WhiteTWTacey E.K. White
- Robert L. ClarkRCRobert L. Clark
- 9 July 2008
- journal article
- research article
- Published by Wiley in Birth Defects Research Part B: Developmental and Reproductive Toxicology
- Vol. 83 (4) , 407-417
Abstract
BACKGROUND: Artesunate has been reported to cause embryolethality and malformations when administered orally to rats during organogenesis. The purpose of this study was to determine the most sensitive period(s) for the induction of these effects in order to provide clues about possible mechanisms and to identify a short treatment regimen for further studies.METHODS: Pregnant rats were orally administered artesunate (10, 17 or 30 mg/kg/day) on single or multiple days of gestation. Cesarean sections and fetal evaluations were conducted on Day 21 postcoitum (pc).RESULTS: Embryolethality, cardiovascular malformations and a syndrome of skeletal defects were observed after single doses on days 10 to 14 pc, while no developmental effects were observed before (day 9 pc) or after (days 16 or 17 pc) that period. The most sensitive day for embryo lethality was day 11 pc, where lethality occurred with a very steep dose response (postimplantation loss was ∼15% at 10 mg/kg and 100% at 17 mg/kg/day). The most sensitive day for the induction of malformations was day 10 pc. Malformations tended to occur in partially resorbed litters and included cardiovascular defects and bent and misshapen long bones and scapulae.CONCLUSIONS: The sensitive window for developmental toxicity of artesunate in the rat was identified as days 10 to 14 pc. Single oral doses produced embryolethality and similar cardiovascular and skeletal malformations as previously reported in longer term dosing experiments. These single dose treatment regimens could be useful to further investigate the mechanistic basis for artesunate‐induced developmental toxicity. Birth Defects Research (Part B) 2008.Keywords
This publication has 35 references indexed in Scilit:
- Hypoxia induces cardiac malformations via A1 adenosine receptor activation in chicken embryosBirth Defects Research Part A: Clinical and Molecular Teratology, 2008
- A1 adenosine receptors play an essential role in protecting the embryo against hypoxiaProceedings of the National Academy of Sciences, 2007
- In vivo and in vitro investigations of the effects of the antimalarial drug dihydroartemisinin (DHA) on rat embryosReproductive Toxicology, 2006
- The global distribution of clinical episodes of Plasmodium falciparum malariaNature, 2005
- The economic and social burden of malariaNature, 2002
- Randomized comparison of quinine-clindamycin versus artesunate in the treatment of falciparum malaria in pregnancyTransactions of the Royal Society of Tropical Medicine and Hygiene, 2001
- Multiple dose study of interactions between artesunate and artemisinin in healthy volunteersBritish Journal of Clinical Pharmacology, 2001
- Spontaneous and induced alterations in the cardiac membranous ventricular septum of fetal, weanling, and adult ratsTeratology, 1997
- Definitive Hematopoiesis Is Autonomously Initiated by the AGM RegionCell, 1996
- Species Difference in Developmental Toxicity of an N‐Phenylimide Herbicide between Rats and Rabbits and Sensitive Period of the Toxicity to Rat EmbryosCongenital Anomalies, 1995